Taisho Pharmaceutical Holdings Co., Ltd.
TAIPY · OTC
12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
|---|---|---|---|---|
| Market Cap | $42,781 | $32,683 | $27,647 | $28,236 |
| - Cash | $246,071 | $240,479 | $248,189 | $255,966 |
| + Debt | $8,886 | $5,842 | $5,770 | $2,590 |
| Enterprise Value | -$194,404 | -$201,954 | -$214,772 | -$225,140 |
| Revenue | $83,576 | $82,295 | $80,802 | $73,712 |
| % Growth | 1.6% | 1.8% | 9.6% | – |
| Gross Profit | $46,480 | $46,915 | $48,280 | $41,490 |
| % Margin | 55.6% | 57% | 59.8% | 56.3% |
| EBITDA | $4,549 | $6,729 | $14,097 | $6,336 |
| % Margin | 5.4% | 8.2% | 17.4% | 8.6% |
| Net Income | $2,873 | $3,087 | $4,363 | -$1,902 |
| % Margin | 3.4% | 3.8% | 5.4% | -2.6% |
| EPS Diluted | 35 | 37.6 | 53.15 | -23.2 |
| % Growth | -6.9% | -29.3% | 329.1% | – |
| Operating Cash Flow | $21,194 | $14,578 | $13,904 | $13,432 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $21,194 | $14,578 | $13,904 | $13,432 |